龙芯中科(688047) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥118,085,837.09, representing a decrease of 34.93% compared to the same period last year[4] - The net profit attributable to shareholders was -¥72,179,159.11, a decline of 298.17% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥95,628,267.60, down 1,041.20% from the previous year[4] - The net profit for Q1 2023 was -72,179,159.11, compared to a net profit of 36,422,454.24 in Q1 2022, indicating a significant decline[20] - The total profit for Q1 2023 was -85,378,967.59, compared to a profit of 40,684,217.32 in Q1 2022, indicating a substantial decline[19] - The basic earnings per share for Q1 2023 was -0.18, compared to 0.10 in Q1 2022, reflecting a negative shift in profitability[20] Research and Development - The total R&D investment amounted to ¥110,218,655.31, an increase of 70.55% compared to the same period last year[6] - R&D investment accounted for 93.34% of operating revenue, up 57.91 percentage points year-on-year[6] - Research and development expenses rose to 95,479,638.96 in Q1 2023, compared to 52,341,901.86 in Q1 2022, marking an increase of about 82.5%[19] Cash Flow and Assets - The net cash flow from operating activities was -¥170,385,454.19, with no applicable comparison[4] - Cash flow from operating activities for Q1 2023 was -170,385,454.19, an improvement from -189,815,343.14 in Q1 2022[22] - Cash and cash equivalents decreased to RMB 266,876,729.56 from RMB 696,341,611.03, representing a decline of 61.7%[15] - Total current assets amounted to RMB 3,572,034,152.74, slightly down from RMB 3,641,542,232.15, a decrease of 1.9%[15] - Total assets at the end of the reporting period were ¥4,318,960,881.43, a decrease of 1.13% from the end of the previous year[6] - The ending balance of cash and cash equivalents was $266,876,729.56, down from $696,341,611.03 at the beginning of the period[23] Liabilities and Equity - The total liabilities increased to RMB 494,651,334.56 from RMB 477,820,000.56, an increase of 3.1%[17] - The equity attributable to shareholders decreased by 1.70% to ¥3,824,309,546.87 compared to the end of the previous year[6] - The company's equity attributable to shareholders decreased to RMB 3,824,309,546.87 from RMB 3,890,520,780.75, a decrease of 1.7%[17] Government Support and Strategic Initiatives - The company received government subsidies amounting to ¥18,843,082.42 during the reporting period[7] - The company is focusing on new product development and market expansion strategies to improve future performance[18] - The report highlights a substantial investment in subsidiaries and other business units, reflecting the company's strategic growth initiatives[23] Management and Reporting - The company’s financial management team is led by Hu Weiwu, with key accounting responsibilities held by Cao Yancai and He Huiru[23] - The report was officially announced by the board of directors on April 24, 2023, indicating timely communication of financial performance[23]